Skip to main content
Fig. 5 | Journal of Hematology & Oncology

Fig. 5

From: Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium

Fig. 5

Development of new age-specific prognostic models. The prognostic model for older patients (≥ 65y) was developed in the training cohort (A) and tested in the validation cohort (B); the prognostic model for younger patients (< 65y) was developed in the training cohort (C) and tested in the validation cohort (D)

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us